It was shown that high levels of circ_0020710 correlate with cytotoxic T-lymphocyte exhaustion in melanoma patients and that combined treatment of the CXCL12 inhibitor AMD3100 and anti PD-(L)1 enhance its therapeutic efficacy in mouse xenograft melanoma models [114]. Here, CXCL12 is linked to melanoma.